{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:30:54Z","timestamp":1789093854445,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"am","delay-in-days":283,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["2I01BX002006"],"award-info":[{"award-number":["2I01BX002006"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI175699"],"award-info":[{"award-number":["R01AI175699"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI140287"],"award-info":[{"award-number":["R01AI140287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.taap.2025.117543","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:51:37Z","timestamp":1757001097000},"page":"117543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicity"],"prefix":"10.1016","volume":"505","author":[{"given":"Cole S.","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh T.","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan D.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sheikh-Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117543_bb0005","doi-asserted-by":"crossref","first-page":"F702","DOI":"10.1152\/ajprenal.00044.2017","article-title":"Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells","volume":"314","author":"Adedoyin","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.taap.2025.117543_bb0010","series-title":"Overview of Antibiotic-Induced Nephrotoxicity","author":"Campbell","year":"2023"},{"key":"10.1016\/j.taap.2025.117543_bb0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1742-7843.2005.pto_153.x","article-title":"Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity","volume":"97","author":"Celik","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2025.117543_bb0020","doi-asserted-by":"crossref","first-page":"F145","DOI":"10.1152\/ajprenal.00164.2016","article-title":"The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction","volume":"311","author":"Chevalier","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.taap.2025.117543_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fphar.2014.00061","article-title":"Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes","volume":"5","author":"Chiabrando","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2025.117543_bb0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bcpt.13799","article-title":"Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: combined retrospective analyses of two real-world databases","volume":"131","author":"Chuma","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2025.117543_bb0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/biom11040589","article-title":"Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions","volume":"11","author":"Consoli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.taap.2025.117543_bb0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/138161208783597407","article-title":"Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections","volume":"14","author":"Cuadrado","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2025.117543_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cmi.2017.06.017","article-title":"Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections\u2014a systematic review and meta-analysis","volume":"24","author":"Diaz","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.taap.2025.117543_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/antiox8100475","article-title":"Role of heme oxygenase as a modulator of heme-mediated pathways","volume":"8","author":"Duvigneau","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.taap.2025.117543_bb0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00228-012-1406-3","article-title":"Prevention of vancomycin induced nephrotoxicity: a review of preclinical data","volume":"69","author":"Elyasi","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2025.117543_bb0060","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/auto.6.5.12189","article-title":"Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy","volume":"6","author":"Fan","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2025.117543_bb0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"key":"10.1016\/j.taap.2025.117543_bb0070","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/ijms22042009","article-title":"Heme oxygenase 1: a defensive mediator in kidney diseases","volume":"22","author":"Grunenwald","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2025.117543_bb0075","doi-asserted-by":"crossref","DOI":"10.21037\/atm-21-3294","article-title":"Vitamin C reduces vancomycin-related nephrotoxicity through the inhibition of oxidative stress, apoptosis, and inflammation in mice","volume":"9","author":"He","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.taap.2025.117543_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2018.01.001","article-title":"Zileuton alleviates acute cisplatin nephrotoxicity: inhibition of lipoxygenase pathway favorably modulates the renal oxidative\/inflammatory\/caspase-3 axis","volume":"135","author":"Helmy","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.taap.2025.117543_bb0085","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1681\/ASN.2016060606","article-title":"Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity","volume":"28","author":"Hori","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.taap.2025.117543_bb0090","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dkad246","article-title":"Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model","volume":"78","author":"Hudson","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.taap.2025.117543_bb0095","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1152\/ajprenal.00029.2024","article-title":"Mechanisms of gelofusine protection in an in vitro model of polymyxin B-associated renal injury","volume":"327","author":"Hudson","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.taap.2025.117543_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00287-25","article-title":"Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicity","volume":"69","author":"Hudson","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2025.117543_bb0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/01913123.2025.2541667","article-title":"Protection against vancomycin-associated nephrotoxicity by zileuton: role of mitochondria revealed by electron microscopic study","volume":"49","author":"Hudson","year":"2025","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.taap.2025.117543_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/704382","article-title":"Protective effects of cilastatin against vancomycin-induced nephrotoxicity","volume":"2015","author":"Humanes","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.taap.2025.117543_bb0115","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.molcel.2013.08.003","article-title":"Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy","volume":"51","author":"Ichimura","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2025.117543_bb0120","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","article-title":"A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia","volume":"29","author":"Jeffres","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.taap.2025.117543_bb0125","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2025.117543_bb0130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4062\/biomolther.2023.062","article-title":"Synergistic renoprotective effect of melatonin and zileuton by inhibition of ferroptosis via the AKT\/mTOR\/NRF2 signaling in kidney injury and fibrosis","volume":"31","author":"Jung","year":"2023","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.taap.2025.117543_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.858462","article-title":"The role of cystine\/glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer","volume":"12","author":"Jyotsana","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2025.117543_bb0140","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s00210-024-03372-5","article-title":"Protective effects of silymarin on preventing vancomycin nephrotoxicity in infectious patients: a randomized, double-blinded, placebo-controlled, pilot clinical trial","volume":"398","author":"Karimian","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.taap.2025.117543_bb0145","first-page":"595","article-title":"Prevention and management of antibiotic associated acute kidney injury in critically ill patients: new insights","volume":"29","author":"Karimzadeh","year":"2023","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.taap.2025.117543_bb0150","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ijms21020560","article-title":"Underlying histopathology determines response to oxidative stress in cultured human primary proximal tubular epithelial cells","volume":"21","author":"Khan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2025.117543_bb0155","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/metabo12070609","article-title":"The role of ferritin in health and disease: recent advances and understandings","volume":"12","author":"Kotla","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.taap.2025.117543_bb0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cellsig.2009.09.014","article-title":"The cardioprotective effects of zileuton, a 5-lipoxygenase inhibitor, are mediated by COX-2 via activation of PKC\u03b4","volume":"22","author":"Kwak","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.taap.2025.117543_bb0165","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1038\/s41598-017-05346-5","article-title":"5-LO inhibition ameliorates palmitic acid-induced ER stress, oxidative stress and insulin resistance via AMPK activation in murine myotubes","volume":"7","author":"Kwak","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2025.117543_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/ars.2016.6659","article-title":"Heme oxygenase-1 in kidney health and disease","volume":"25","author":"Lever","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2025.117543_bb0175","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1164\/rccm.201311-2097OC","article-title":"Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill","volume":"189","author":"Linder","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2025.117543_bb0180","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1248\/bpb.b15-00048","article-title":"The 5-lipoxygenase inhibitor zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis","volume":"38","author":"Liu","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2025.117543_bb0185","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1128\/AAC.02445-15","article-title":"Characterization of polymyxin B biodistribution and disposition in an animal model","volume":"60","author":"Manchandani","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2025.117543_bb0190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10245330500093419","article-title":"Divalent metal transporter 1","volume":"10","author":"Mims","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.taap.2025.117543_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295136","article-title":"Vancomycin nephrotoxicity: a comprehensive clinico-pathological study","volume":"19","author":"Nachiappa Ganesh","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2025.117543_bb0200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1179\/135100002125000884","article-title":"Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat","volume":"7","author":"Nishino","year":"2002","journal-title":"Redox Rep."},{"key":"10.1016\/j.taap.2025.117543_bb0205","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/1071576031000061002","article-title":"Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats","volume":"37","author":"Nishino","year":"2003","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.taap.2025.117543_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175688","article-title":"Vancomycin-associated acute kidney injury: a cross-sectional study from a single center in China","volume":"12","author":"Pan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2025.117543_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01545-18","article-title":"Rutin attenuates vancomycin-induced nephrotoxicity by ameliorating oxidative stress, apoptosis, and inflammation in rats","volume":"63","author":"Qu","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2025.117543_bb0220","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.taap.2025.117543_bb0225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1165\/rcmb.2009-0170TR","article-title":"Heme oxygenase-1\/carbon monoxide: from metabolism to molecular therapy","volume":"41","author":"Ryter","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.taap.2025.117543_bb0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2017.02.025","article-title":"Vancomycin induces reactive oxygen species-dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells","volume":"800","author":"Sakamoto","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117543_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2025.115264","article-title":"Aprepitant ameliorates vancomycin-induced kidney injury: role of GPX4\/system xc\u2212 and oxidative damage","volume":"197","author":"Sharawy","year":"2025","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2025.117543_bb0240","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1002\/j.2040-4603.2024.tb00287.x","article-title":"Renal epithelial mitochondria: implications for hypertensive kidney disease","volume":"14","author":"Stadler","year":"2023","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.taap.2025.117543_bb0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.47275\/0032-745X-145","article-title":"Comparative protective effect of zileuton and MK-886 against acute kidney injury induced by doxorubicin","volume":"105","author":"Sultan","year":"2019","journal-title":"Prensa Med. Argent."},{"key":"10.1016\/j.taap.2025.117543_bb0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5414\/CNCS109817","article-title":"Vancomycin nephrotoxicity: vancomycin tubular casts with characteristic electron microscopic findings","volume":"7","author":"Tantranont","year":"2019","journal-title":"Clin. Nephrol. Case Stud."},{"key":"10.1016\/j.taap.2025.117543_bb0255","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ekir.2021.04.035","article-title":"Vancomycin-associated tubular casts and vancomycin nephrotoxicity","volume":"6","author":"Tantranont","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.taap.2025.117543_bb0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/jiaf027","article-title":"Reduction of vancomycin-associated acute kidney injury with montelukast","volume":"232","author":"Teran","year":"2025","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.taap.2025.117543_bb0265","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/08998280.2016.11929491","article-title":"Acute renal failure due to vancomycin toxicity in the setting of unmonitored vancomycin infusion","volume":"29","author":"Vora","year":"2016","journal-title":"Proc. (Baylor Univ. Med. Cent.)"},{"key":"10.1016\/j.taap.2025.117543_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7536803","article-title":"The 5-lipoxygenase inhibitor zileuton protects pressure overload-induced cardiac Remodeling via activating PPARalpha","volume":"2019","author":"Wu","year":"2019","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:05:13Z","timestamp":1780722313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25003199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"alternative-id":["S0041008X25003199"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117543","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicity","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117543"}}